RAD001 Plus Octreotide Depot in Metastatic or Unresectable Low Grade Neuroendocrine Carcinoma
Clinical trial NCT00113360 · COMPLETED
Trial details
- NCT number
- NCT00113360
- Sponsor
- M.D. Anderson Cancer Center
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2005-01-01
- Primary completion
- 2009-07-01
- Enrollment
- 67
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.